tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market
NAMS
NewAmsterdam Pharma Company
RESEARCH TOOLSreports

NewAmsterdam Pharma Company (NAMS) Stock News & Sentiment

249 Followers
NewAmsterdam Highlights Obicetrapib Progress in Investor Presentation
Premium
Company Announcements
NewAmsterdam Highlights Obicetrapib Progress in Investor Presentation
1M ago
8K
NAMS
Reaffirming Buy on NewAmsterdam Pharma: Optimized Expense Outlook and Milestone Upside Strengthen Risk‑Reward Profile
Premium
Ratings
Reaffirming Buy on NewAmsterdam Pharma: Optimized Expense Outlook and Milestone Upside Strengthen Risk‑Reward Profile
2M ago
NAMS
NewAmsterdam Pharma (NAMS): Buy Rating on Strong PREVAIL Momentum, Broad Phase 3 Cardiovascular Program, and Solid Cash Runway
Premium
Ratings
NewAmsterdam Pharma (NAMS): Buy Rating on Strong PREVAIL Momentum, Broad Phase 3 Cardiovascular Program, and Solid Cash Runway
2M ago
NAMS
3 ‘Strong Buy’ Stocks to Buy Today, 1/14/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today, 1/14/2026, According to Top Analysts
3M ago
CYTK
MNPR
NewAmsterdam Pharma: PREVAIL Parallels, Robust Trial Execution, and 2026 Milestones Support Buy Rating
Premium
Ratings
NewAmsterdam Pharma: PREVAIL Parallels, Robust Trial Execution, and 2026 Milestones Support Buy Rating
3M ago
NAMS
NewAmsterdam Pharma: Obicetrapib Momentum, 2026 Inflection Catalysts, and Undervalued Blockbuster Potential Support Buy Rating
Premium
Ratings
NewAmsterdam Pharma: Obicetrapib Momentum, 2026 Inflection Catalysts, and Undervalued Blockbuster Potential Support Buy Rating
3M ago
NAMS
NewAmsterdam Pharma: Late-Stage Obicetrapib Momentum, Regulatory Catalysts, and Strong Cash Position Underpin Buy Rating
Premium
Ratings
NewAmsterdam Pharma: Late-Stage Obicetrapib Momentum, Regulatory Catalysts, and Strong Cash Position Underpin Buy Rating
3M ago
NAMS
More NAMS News >

NAMS News on the Web

Why NewAmsterdam Pharma Stock Is Suddenly Surging
TipRanks News
Bullish
NewAmsterdam Pharma Company (NAMS) Receives a Buy from Wells Fargo
TipRanks News
Bullish
NewAmsterdam Pharma Jumps on Powerful Trial Breakthrough
TipRanks News
Bullish
Why NewAmsterdam Pharma Stock Is Quietly Surging
TipRanks News
Bullish
NewAmsterdam Pharma initiated with a Buy at Truist
TipRanks News
Bullish
NewAmsterdam Pharma Director Makes Major Stock Move in High-Value Sale
TipRanks News
Neutral
Insider Sell: Louis Lange Sells 44,619 Shares of NewAmsterdam Pharma Co NV
GuruFocus News
Bearish
NewAmsterdam Pharma Company NV at TD Cowen Healthcare Conference Transcript
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
NAMS
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NAMS’s Media Buzz Sentiment?
1 articles about NAMS were published this week. In an average week, 1.25 articles are published.
    What is NAMS’s weekly average amount of articles?
    In an average week, 1.25 articles about NAMS are published.
      What is NAMS’s News Sentiment?
      100% of articles about NAMS were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week